IFITM1 and neoplasm: Moreover, the low expression of IFITM1 was also related to worse overall survival in the T stage (p = 0.031), the white subgroup of the race (p = 0.049), N stage (p = 0.035), M stage (p = 0.018), and residual tumor (p = 0.038) (Figures 3B, –F).